▶ 調査レポート

アルツハイマー病治療薬の世界市場レポート2020

• 英文タイトル:Global Alzheimer's Disease Drug Sales Market Report 2020

QYResearchが調査・発行した産業分析レポートです。アルツハイマー病治療薬の世界市場レポート2020 / Global Alzheimer's Disease Drug Sales Market Report 2020 / 20QY06-00719資料のイメージです。• レポートコード:20QY06-00719
• 出版社/出版日:QYResearch / 2020年6月3日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、134ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥592,000 (USD4,000)▷ お問い合わせ
  Multi User¥888,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,184,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社の当調査資料では、アルツハイマー病治療薬のグローバル市場について種類別(ドネペジル、メマンチン、リバスチグミン)、用途別(初期-中等度段階、中等度-重度段階)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。

・アルツハイマー病治療薬市場の概要
・世界の主要地域別アルツハイマー病治療薬市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のアルツハイマー病治療薬市場規模2015-2026:種類別(ドネペジル、メマンチン、リバスチグミン)
・世界のアルツハイマー病治療薬市場規模2015-2026:用途別(初期-中等度段階、中等度-重度段階)
・アルツハイマー病治療薬の北米市場規模2015-2020
・アルツハイマー病治療薬のヨーロッパ市場規模2015-2020
・アルツハイマー病治療薬の中国市場規模2015-2020
・アルツハイマー病治療薬の日本市場規模2015-2020
・アルツハイマー病治療薬の東南アジア市場規模2015-2020
・アルツハイマー病治療薬のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Allergan、Eisai、Novartis、Daiichi Sankyo、Merz Pharma、Pfizer、Johnson & Johnson、Lundbeck)
・アルツハイマー病治療薬の製造コスト分析
・販売チャネル、流通業者、顧客
・アルツハイマー病治療薬の市場動向・機会・課題
・調査の結論

A recently published report by QY Research titled Global Alzheimer’s Disease Drug Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Alzheimer’s Disease Drug market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Alzheimer’s disease (AD), also referred to simply as Alzheimer’s, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Alzheimer’s Disease Drug market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Alzheimer’s Disease Drug industry.
Based on our recent survey, we have several different scenarios about the Alzheimer’s Disease Drug YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 2249.4 million in 2019. The market size of Alzheimer’s Disease Drug will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Alzheimer’s Disease Drug market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Alzheimer’s Disease Drug market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Alzheimer’s Disease Drug market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Alzheimer’s Disease Drug market. The report also includes nautical information, where it shows Alzheimer’s Disease Drug market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Alzheimer’s Disease Drug market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Alzheimer’s Disease Drug market.
Alzheimer’s disease drug are widely used for Early to Moderate, Moderate to Severe stage treatment. The most proportion of alzheimer’s disease drug used to Moderate to Severe, and the market share in 2016 is 55.82%.The classification of alzheimer’s disease drug includes Memantine, Donepezil, Rivastigmine and Others, and the proportion of Memantine in 2016 is about 49.28%. The market for Donepezil, is decreast quickly in past five years.
Geographical Analysis:
Based on region, the global Alzheimer’s Disease Drug market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Alzheimer’s Disease Drug market are
Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck
Segment by Type
Donepezil
Memantine
Rivastigmine
Segment by Application
Early to Moderate Stages
Moderate to Severe Stages
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Alzheimer’s Disease Drug market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Alzheimer’s Disease Drug market.
• The market share of the global Alzheimer’s Disease Drug market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Alzheimer’s Disease Drug market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Alzheimer’s Disease Drug market.

レポート目次

1 Alzheimer’s Disease Drug Market Overview
1.1 Alzheimer’s Disease Drug Product Scope
1.2 Alzheimer’s Disease Drug Segment by Type
1.2.1 Global Alzheimer’s Disease Drug Sales by Type (2020-2026)
1.2.2 Donepezil
1.2.3 Memantine
1.2.4 Rivastigmine
1.3 Alzheimer’s Disease Drug Segment by Application
1.3.1 Global Alzheimer’s Disease Drug Sales Comparison by Application (2020-2026)
1.3.2 Early to Moderate Stages
1.3.3 Moderate to Severe Stages
1.4 Alzheimer’s Disease Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Alzheimer’s Disease Drug Sales Growth Rate (2015-2026)
1.4.2 Global Alzheimer’s Disease Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Alzheimer’s Disease Drug Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Alzheimer’s Disease Drug Industry Impact
1.5.1 How the Covid-19 is Affecting the Alzheimer’s Disease Drug Industry
1.5.1.1 Alzheimer’s Disease Drug Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Alzheimer’s Disease Drug Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Alzheimer’s Disease Drug Players to Combat Covid-19 Impact

2 Alzheimer’s Disease Drug Estimate and Forecast by Region
2.1 Global Alzheimer’s Disease Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Alzheimer’s Disease Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Alzheimer’s Disease Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Alzheimer’s Disease Drug Revenue Market Share by Region (2015-2020)
2.3 Global Alzheimer’s Disease Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Alzheimer’s Disease Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Alzheimer’s Disease Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Alzheimer’s Disease Drug Estimates and Projections (2015-2026)
2.4.2 Europe Alzheimer’s Disease Drug Estimates and Projections (2015-2026)
2.4.3 China Alzheimer’s Disease Drug Estimates and Projections (2015-2026)
2.4.4 Japan Alzheimer’s Disease Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Alzheimer’s Disease Drug Estimates and Projections (2015-2026)
2.4.6 India Alzheimer’s Disease Drug Estimates and Projections (2015-2026)
3 Global Alzheimer’s Disease Drug Competition Landscape by Players
3.1 Global Top Alzheimer’s Disease Drug Players by Sales (2015-2020)
3.2 Global Top Alzheimer’s Disease Drug Players by Revenue (2015-2020)
3.3 Global Alzheimer’s Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimer’s Disease Drug as of 2019)
3.4 Global Alzheimer’s Disease Drug Average Price by Company (2015-2020)
3.5 Manufacturers Alzheimer’s Disease Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Alzheimer’s Disease Drug Players (Opinion Leaders)
4 Global Alzheimer’s Disease Drug Market Size by Type
4.1 Global Alzheimer’s Disease Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Alzheimer’s Disease Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Alzheimer’s Disease Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Alzheimer’s Disease Drug Price by Type (2014-2020)
4.2 Global Alzheimer’s Disease Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Alzheimer’s Disease Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Alzheimer’s Disease Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Alzheimer’s Disease Drug Price Forecast by Type (2021-2026)
5 Global Alzheimer’s Disease Drug Market Size by Application
5.1 Global Alzheimer’s Disease Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Alzheimer’s Disease Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Alzheimer’s Disease Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Alzheimer’s Disease Drug Price by Application (2015-2020)
5.2 Global Alzheimer’s Disease Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Alzheimer’s Disease Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Alzheimer’s Disease Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Alzheimer’s Disease Drug Price Forecast by Application (2021-2026)

3 North America Alzheimer’s Disease Drug Market Facts & Figures
3.2 North America Alzheimer’s Disease Drug Sales Market Share by Company (2015-2020)
3.3 North America Alzheimer’s Disease Drug Sales Market Share by Type (2015-2020)
3.4 North America Alzheimer’s Disease Drug Sales Market Share by Application (2015-2020)

4 Europe Alzheimer’s Disease Drug Market Facts & Figures
4.2 Europe Alzheimer’s Disease Drug Sales Market Share by Company (2015-2020)
4.3 Europe Alzheimer’s Disease Drug Sales Market Share by Type (2015-2020)
4.4 Europe Alzheimer’s Disease Drug Sales Market Share by Application (2015-2020)

5 China Alzheimer’s Disease Drug Market Facts & Figures
5.2 China Alzheimer’s Disease Drug Sales Market Share by Company (2015-2020)
5.3 China Alzheimer’s Disease Drug Sales Market Share by Type (2015-2020)
5.4 China Alzheimer’s Disease Drug Sales Market Share by Application (2015-2020)

6 Japan Alzheimer’s Disease Drug Market Facts & Figures
6.2 Japan Alzheimer’s Disease Drug Sales Market Share by Company (2015-2020)
6.3 Japan Alzheimer’s Disease Drug Sales Market Share by Type (2015-2020)
6.4 Japan Alzheimer’s Disease Drug Sales Market Share by Application (2015-2020)

7 Southeast Asia Alzheimer’s Disease Drug Market Facts & Figures
7.2 Southeast Asia Alzheimer’s Disease Drug Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Alzheimer’s Disease Drug Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Alzheimer’s Disease Drug Sales Market Share by Application (2015-2020)

8 India Alzheimer’s Disease Drug Market Facts & Figures
8.2 India Alzheimer’s Disease Drug Sales Market Share by Company (2015-2020)
8.3 India Alzheimer’s Disease Drug Sales Market Share by Type (2015-2020)
8.4 India Alzheimer’s Disease Drug Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Alzheimer’s Disease Drug Business
12.1 Allergan
12.1.1 Allergan Alzheimer’s Disease Drug Corporation Information
12.1.2 Allergan Alzheimer’s Disease Drug Business Overview and Total Revenue
12.1.3 Allergan Alzheimer’s Disease Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Allergan Alzheimer’s Disease Drug Products Offered
12.1.5 Allergan Recent Development
12.2 Eisai
12.2.1 Eisai Alzheimer’s Disease Drug Corporation Information
12.2.2 Eisai Alzheimer’s Disease Drug Business Overview and Total Revenue
12.2.3 Eisai Alzheimer’s Disease Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Eisai Alzheimer’s Disease Drug Products Offered
12.2.5 Eisai Recent Development
12.3 Novartis
12.3.1 Novartis Alzheimer’s Disease Drug Corporation Information
12.3.2 Novartis Alzheimer’s Disease Drug Business Overview and Total Revenue
12.3.3 Novartis Alzheimer’s Disease Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Novartis Alzheimer’s Disease Drug Products Offered
12.3.5 Novartis Recent Development
12.4 Daiichi Sankyo
12.4.1 Daiichi Sankyo Alzheimer’s Disease Drug Corporation Information
12.4.2 Daiichi Sankyo Alzheimer’s Disease Drug Business Overview and Total Revenue
12.4.3 Daiichi Sankyo Alzheimer’s Disease Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Daiichi Sankyo Alzheimer’s Disease Drug Products Offered
12.4.5 Daiichi Sankyo Recent Development
12.5 Merz Pharma
12.5.1 Merz Pharma Alzheimer’s Disease Drug Corporation Information
12.5.2 Merz Pharma Alzheimer’s Disease Drug Business Overview and Total Revenue
12.5.3 Merz Pharma Alzheimer’s Disease Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Merz Pharma Alzheimer’s Disease Drug Products Offered
12.5.5 Merz Pharma Recent Development
12.6 Pfizer
12.6.1 Pfizer Alzheimer’s Disease Drug Corporation Information
12.6.2 Pfizer Alzheimer’s Disease Drug Business Overview and Total Revenue
12.6.3 Pfizer Alzheimer’s Disease Drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Pfizer Alzheimer’s Disease Drug Products Offered
12.6.5 Pfizer Recent Development
12.7 Johnson & Johnson
12.7.1 Johnson & Johnson Alzheimer’s Disease Drug Corporation Information
12.7.2 Johnson & Johnson Alzheimer’s Disease Drug Business Overview and Total Revenue
12.7.3 Johnson & Johnson Alzheimer’s Disease Drug Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Johnson & Johnson Alzheimer’s Disease Drug Products Offered
12.7.5 Johnson & Johnson Recent Development
12.8 Lundbeck
12.8.1 Lundbeck Alzheimer’s Disease Drug Corporation Information
12.8.2 Lundbeck Alzheimer’s Disease Drug Business Overview and Total Revenue
12.8.3 Lundbeck Alzheimer’s Disease Drug Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Lundbeck Alzheimer’s Disease Drug Products Offered
12.8.5 Lundbeck Recent Development

13 Alzheimer’s Disease Drug Manufacturing Cost Analysis
13.1 Alzheimer’s Disease Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Alzheimer’s Disease Drug
13.4 Alzheimer’s Disease Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Alzheimer’s Disease Drug Distributors List
14.3 Alzheimer’s Disease Drug Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Alzheimer's Disease Drug Sales (M Units) Growth Rate by Type (2020-2026)
Table 2. Global Alzheimer's Disease Drug Sales (M Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Alzheimer's Disease Drug Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Alzheimer's Disease Drug Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Alzheimer's Disease Drug Players to Combat Covid-19 Impact
Table 8. Global Market Alzheimer's Disease Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Alzheimer's Disease Drug Sales (M Units) by Region (2015-2020)
Table 10. Global Alzheimer's Disease Drug Sales Market Share by Region (2015-2020)
Table 11. Global Alzheimer's Disease Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Alzheimer's Disease Drug Revenue Share by Region (2015-2020)
Table 13. Global Alzheimer's Disease Drug Sales (M Units) Forecast by Region (2021-2026)
Table 14. Global Alzheimer's Disease Drug Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Alzheimer's Disease Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Alzheimer's Disease Drug Revenue Share Forecast by Region (2021-2026)
Table 17. Global Alzheimer's Disease Drug (M Units) of Key Companies (2015-2020)
Table 18. Global Alzheimer's Disease Drug Sales Share by Company (2015-2020)
Table 19. Global Alzheimer's Disease Drug Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Alzheimer's Disease Drug Revenue Share by Company (2015-2020)
Table 21. Global Alzheimer's Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimer's Disease Drug as of 2019)
Table 22. Global Alzheimer's Disease Drug Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Alzheimer's Disease Drug Manufacturing Sites and Area Served
Table 24. Manufacturers Alzheimer's Disease Drug Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Alzheimer's Disease Drug Players
Table 27. Global Alzheimer's Disease Drug Sales (M Units) by Type (2015-2020)
Table 28. Global Alzheimer's Disease Drug Sales Share by Type (2015-2020)
Table 29. Global Alzheimer's Disease Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Alzheimer's Disease Drug Price (M Units) by Type (2015-2020)
Table 31. Global Alzheimer's Disease Drug Sales Share by Type (2021-2026)
Table 32. Global Alzheimer's Disease Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Alzheimer's Disease Drug Revenue Share by Type (2021-2026)
Table 34. Global Alzheimer's Disease Drug Price (M Units) by Type (2021-2026)
Table 35. Global Alzheimer's Disease Drug Sales (M Units) by Application (2015-2020)
Table 36. Global Alzheimer's Disease Drug Sales Share by Application (2015-2020)
Table 37. Global Alzheimer's Disease Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Alzheimer's Disease Drug Price (M Units) by Application (2015-2020)
Table 39. Global Alzheimer's Disease Drug Sales (M Units) by Application (2021-2026)
Table 40. Global Alzheimer's Disease Drug Sales Share by Application (2021-2026)
Table 41. Global Alzheimer's Disease Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Alzheimer's Disease Drug Revenue Share by Application (2021-2026)
Table 43. Global Alzheimer's Disease Drug Price (M Units) by Application (2021-2026)
Table 44. United States Alzheimer's Disease Drug Sales (M Units) by Company (2015-2020)
Table 45. United States Alzheimer's Disease Drug Sales Market Share by Company (2015-2020)
Table 46. United States Alzheimer's Disease Drug Sales (M Units) by Type (2015-2020)
Table 47. United States Alzheimer's Disease Drug Sales Market Share by Type (2015-2020)
Table 48. United States Alzheimer's Disease Drug Sales (M Units) by Application (2015-2020)
Table 49. United States Alzheimer's Disease Drug Sales Market Share by Application (2015-2020)
Table 50. Europe Alzheimer's Disease Drug Sales (M Units) by Company (2015-2020)
Table 51. Europe Alzheimer's Disease Drug Sales Market Share by Company (2015-2020)
Table 52. Europe Alzheimer's Disease Drug Sales (M Units) by Type (2015-2020)
Table 53. Europe Alzheimer's Disease Drug Sales Market Share by Type (2015-2020)
Table 54. Europe Alzheimer's Disease Drug Sales (M Units) by Application (2015-2020)
Table 55. Europe Alzheimer's Disease Drug Sales Market Share by Type (2015-2020)
Table 56. China Alzheimer's Disease Drug Sales (M Units) by Company (2015-2020)
Table 57. China Alzheimer's Disease Drug Sales Market Share by Company (2015-2020)
Table 58. China Alzheimer's Disease Drug Sales (M Units) by Type (2015-2020)
Table 59. China Alzheimer's Disease Drug Sales Market Share by Type (2015-2020)
Table 60. China Alzheimer's Disease Drug Sales (M Units) by Application (2015-2020)
Table 61. China Alzheimer's Disease Drug Sales Market Share by Application (2015-2020)
Table 62. Japan Alzheimer's Disease Drug Sales (M Units) by Company (2015-2020)
Table 63. Japan Alzheimer's Disease Drug Sales Market Share by Company (2015-2020)
Table 64. Japan Alzheimer's Disease Drug Sales (M Units) by Type (2015-2020)
Table 65. Japan Alzheimer's Disease Drug Sales Market Share by Type (2015-2020)
Table 66. Japan Alzheimer's Disease Drug Sales (M Units) by Application (2015-2020)
Table 67. Japan Alzheimer's Disease Drug Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Alzheimer's Disease Drug Sales (M Units) by Company (2015-2020)
Table 69. Southeast Asia Alzheimer's Disease Drug Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Alzheimer's Disease Drug Sales (M Units) by Type (2015-2020)
Table 71. Southeast Asia Alzheimer's Disease Drug Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Alzheimer's Disease Drug Sales (M Units) by Type (2015-2020)
Table 73. Southeast Asia Alzheimer's Disease Drug Sales Market Share by Application (2015-2020)
Table 74. India Alzheimer's Disease Drug Sales (M Units) by Company (2015-2020)
Table 75. India Alzheimer's Disease Drug Sales Market Share by Company (2015-2020)
Table 76. India Alzheimer's Disease Drug Sales (M Units) by Type (2015-2020)
Table 77. India Alzheimer's Disease Drug Sales Market Share by Type (2015-2020)
Table 78. India Alzheimer's Disease Drug Sales (M Units) by Application (2015-2020)
Table 79. India Alzheimer's Disease Drug Sales Market Share by Application (2015-2020)
Table 80. Allergan Corporation Information
Table 81. Allergan Description and Business Overview
Table 82. Allergan Alzheimer's Disease Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Allergan Alzheimer's Disease Drug Product
Table 84. Allergan Recent Development
Table 85. Eisai Corporation Information
Table 86. Eisai Description and Business Overview
Table 87. Eisai Alzheimer's Disease Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Eisai Alzheimer's Disease Drug Product
Table 89. Eisai Recent Development
Table 90. Novartis Corporation Information
Table 91. Novartis Description and Business Overview
Table 92. Novartis Alzheimer's Disease Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Novartis Alzheimer's Disease Drug Product
Table 94. Novartis Recent Development
Table 95. Daiichi Sankyo Corporation Information
Table 96. Daiichi Sankyo Description and Business Overview
Table 97. Daiichi Sankyo Alzheimer's Disease Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Daiichi Sankyo Alzheimer's Disease Drug Product
Table 99. Daiichi Sankyo Recent Development
Table 100. Merz Pharma Corporation Information
Table 101. Merz Pharma Description and Business Overview
Table 102. Merz Pharma Alzheimer's Disease Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Merz Pharma Alzheimer's Disease Drug Product
Table 104. Merz Pharma Recent Development
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Business Overview
Table 107. Pfizer Alzheimer's Disease Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Pfizer Alzheimer's Disease Drug Product
Table 109. Pfizer Recent Development
Table 110. Johnson & Johnson Corporation Information
Table 111. Johnson & Johnson Description and Business Overview
Table 112. Johnson & Johnson Alzheimer's Disease Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Johnson & Johnson Alzheimer's Disease Drug Product
Table 114. Johnson & Johnson Recent Development
Table . Lundbeck Corporation Information
Table . Lundbeck Alzheimer's Disease Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Lundbeck Description and Business Overview
Table . Lundbeck Alzheimer's Disease Drug Product
Table . Lundbeck Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Alzheimer's Disease Drug Distributors List
Table 123. Alzheimer's Disease Drug Customers List
Table 124. Market Key Trends
Table 125. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 126. Key Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Alzheimer's Disease Drug Product Picture
Figure 2. Global Alzheimer's Disease Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Alzheimer's Disease Drug Market Share by Application in 2020 & 2026
Figure 6. Early to Moderate Stages Examples
Figure 7. Moderate to Severe Stages Examples
Figure 8. Global Alzheimer's Disease Drug Sales (M Units) Growth Rate (2015-2026)
Figure 9. Global Alzheimer's Disease Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Alzheimer's Disease Drug Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 11. Global Alzheimer's Disease Drug Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Alzheimer's Disease Drug Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Alzheimer's Disease Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Alzheimer's Disease Drug Sales (M Units) Growth Rate (2015-2026)
Figure 15. Europe Alzheimer's Disease Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Alzheimer's Disease Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Alzheimer's Disease Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Alzheimer's Disease Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Alzheimer's Disease Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Alzheimer's Disease Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Alzheimer's Disease Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Alzheimer's Disease Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Alzheimer's Disease Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Alzheimer's Disease Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Alzheimer's Disease Drug Players Market Share by Revenue in Alzheimer's Disease Drug 2015 & 2019
Figure 26. Alzheimer's Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Alzheimer's Disease Drug Revenue Share by Type (2015-2020)
Figure 28. Global Alzheimer's Disease Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Alzheimer's Disease Drug Revenue Share by Application (2015-2020)
Figure 30. Global Alzheimer's Disease Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Alzheimer's Disease Drug Sales Market Share by Type in 2019
Figure 32. United States Alzheimer's Disease Drug Sales Market Share by Type in 2019
Figure 33. Europe Alzheimer's Disease Drug Sales Market Share by Company in 2019
Figure 34. Europe Alzheimer's Disease Drug Sales Market Share by Type in 2019
Figure 35. Europe Alzheimer's Disease Drug Sales Market Share by Application in 2019
Figure 36. China Alzheimer's Disease Drug Sales Market Share by Company in 2019
Figure 37. China Alzheimer's Disease Drug Sales Market Share by Type in 2019
Figure 38. China Alzheimer's Disease Drug Sales Market Share by Application in 2019
Figure 39. Japan Alzheimer's Disease Drug Sales Market Share by Company in 2019
Figure 40. Japan Alzheimer's Disease Drug Sales Market Share by Type in 2019
Figure 41. Japan Alzheimer's Disease Drug Sales Market Share by Application in 2019
Figure 42. Southeast Asia Alzheimer's Disease Drug Sales Market Share by Company in 2019
Figure 43. Southeast Asia Alzheimer's Disease Drug Sales Market Share by Type in 2019
Figure 44. Southeast Asia Alzheimer's Disease Drug Sales Market Share by Application in 2019
Figure 45. India Alzheimer's Disease Drug Sales Market Share by Company in 2019
Figure 46. India Alzheimer's Disease Drug Sales Market Share by Type in 2019
Figure 47. India Alzheimer's Disease Drug Sales Market Share by Application in 2019
Figure 48. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Eisai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Merz Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Lundbeck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Key Raw Materials Price Trend
Figure 57. Manufacturing Cost Structure of Alzheimer's Disease Drug
Figure 58. Manufacturing Process Analysis of Alzheimer's Disease Drug
Figure 59. Alzheimer's Disease Drug Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Porter's Five Forces Analysis
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed